Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement.  Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.

MORE NEWS
  • 18Mai

    We now offer affordable ultra-sensitive biomarker detection with Simoa™ technology

    Read More →
  • 04Mai

    The changing environment in pyrogen and endotoxin testing

    Read More →
  • 04Mai

    Meet us at the Lonza Endotoxin Summit Annapolis, USA

    Read More →
  • 04Mai

    Meet us at the PharmaLab 2018 Düsseldorf/Neuss, Germany

    Read More →
  • 27Feb

    Low Endotoxin Recovery/Masking Training Munich/Bernried, Germany

    Read More →
  • 12Jan

    pLDH recombinant panels for malaria diagnostic tests

    Read More →
  • 04Sep

    Press release: HRP2 recombinant panel now available for malaria rapid diagnostic tests

    Read More →
  • 22Jun

    Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

    Read More →
  • 14Jun

    Microcoat announces the launch of WATSON bioanalytical LIMS

    Read More →
  • 31Jan

    Press release: Positive control wells now available for rapid on-site quality assurance of Malaria rapid tests

    Read More →